Consequently, BMP signaling (BMP2/4) has no change after VA treatment (data not shown), but the enhanced level of β-catenin in HFs and decreased level of FGF5 of HFs and dWAT were proven (Figures 5E,F). The gene discussed is BMP2; the disease is Hand-foot syndrome.